|
STXBP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.663900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.214800E-04 |
| Normal-vs-Stage2 |
7.248000E-01 |
| Normal-vs-Stage3 |
9.518200E-01 |
| Normal-vs-Stage4 |
4.102600E-01 |
| Stage1-vs-Stage2 |
2.362000E-01 |
| Stage1-vs-Stage3 |
9.518400E-02 |
| Stage1-vs-Stage4 |
4.171400E-01 |
| Stage2-vs-Stage3 |
7.573200E-01 |
| Stage2-vs-Stage4 |
7.548400E-01 |
| Stage3-vs-Stage4 |
5.806000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.282860E-03 |
| Normal-vs-AfricanAmerican |
3.004000E-01 |
| Normal-vs-Asian |
3.515800E-01 |
| Caucasian-vs-AfricanAmerican |
1.590990E-01 |
| Caucasian-vs-Asian |
6.852200E-01 |
| AfricanAmerican-vs-Asian |
9.230000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.66069999999663E-05 |
| Normal-vs-Female |
2.518200E-01 |
| Male-vs-Female |
6.01590000000041E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.004800E-01 |
| Normal-vs-Extreme_Weight |
4.34680000005461E-06 |
| Normal-vs-Obese |
5.568600E-01 |
| Normal-vs-Extreme_Obese |
8.377800E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.010300E-02 |
| Normal_Weight-vs-Obese |
8.210800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.998200E-02 |
| Extreme_Weight-vs-Obese |
6.719400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.523000E-01 |
| Obese-vs-Extreme_Obese |
2.217600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.156000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.212400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.569600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.48860000004358E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.763900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.588100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.684300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.081600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.92820000000293E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.543500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.006510E-04 |
| Normal-VS-Type2 PRCC |
3.602100E-03 |
| Normal-VS-KIRP CIMP |
1.812160E-02 |
| Normal-VS-Unclassified PRCC |
2.061600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.660000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.738200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.083810E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.464100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.651200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.335600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.562460E-03 |
| Normal-vs-N1 |
3.089200E-01 |
| Normal-vs-N2 |
3.060800E-01 |
| N0-vs-N1 |
2.155700E-02 |
| N0-vs-N2 |
6.413800E-01 |
| N1-vs-N2 |
4.324800E-01 |
|
|
